DOGP.US Dogecoin Cash, Inc.
- Market cap
- USD 829K
- P/E
- -
- P/B
- 2.13x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is DOGP.US undervalued?
Graham numberThe Graham number of Dogecoin Cash, Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Dogecoin Cash, Inc. fundamental analysis
No fundamental analysis for Dogecoin Cash, Inc. yet.
Dogecoin Cash, Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Dogecoin Cash, Inc.
Dogecoin Cash, Inc., through its subsidiaries, provides online telehealth referral services through the PrestoDoctor platform in the United States. The company offers the technology platform and administrative support that facilitate telemedicine consultations between patients and licensed physicians. In addition, it maintains cannabis-related intellectual property. The company was formerly known as Cannabis Sativa, Inc. and changed its name to Dogecoin Cash, Inc. in Novembe…
Full company profileDogecoin Cash, Inc. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Dogecoin Cash, Inc. annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 1.84M | 1.56M | 1.17M | 803K | 739K | 719K |
| Gross Profit | 1.14M | 961K | 773K | 492K | 473K | 461K |
| Operating Income | -1.75M | -1.40M | -856K | -693K | -547K | -540K |
| EBITDA | - | -1.07M | -1.11M | -1.56M | -9.95M | -620K |
| Net Income | -2.45M | -1.22M | -1.39M | -1.73M | -573K | -650K |
| EPS | -0.08 | -0.03 | -0.02 | -0.01 | 0.00 | 0.00 |
| Balance Sheet | ||||||
| Total Assets | 2.56M | 2.57M | 2.02M | 1.71M | 2.23M | 2.17M |
| Total Liabilities | 1.52M | 986K | 1.26M | 1.84M | 2.26M | 2.49M |
| Shareholders' Equity | -293K | 294K | -602K | -1.44M | -1.87M | -2.15M |
| Cash & Short-term Investments | 194K | 97.4K | 83.8K | 34.9K | 29.6K | 11.0K |
| Cash Flow | ||||||
| Operating Cash Flow | -246K | -236K | -63.1K | -108K | -39.6K | -44.3K |
| Capital Expenditure | 0.00 | 1.59K | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | -246K | -237K | -63.1K | -108K | -39.6K | -44.3K |
| Ratios | ||||||
| ROE | - | -413.5% | - | - | - | - |
| ROA | -95.5% | -47.3% | -68.9% | -101.2% | -25.7% | -30.0% |
| Net Profit Margin | -132.9% | -78.0% | -118.6% | -215.6% | -77.6% | -90.4% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Dogecoin Cash, Inc. dividends
Dogecoin Cash, Inc. has not paid dividends in the last 5 fiscal years.
Who owns Dogecoin Cash, Inc.
- Insiders 25.28%
- Institutions 0.00%
- Public & others 74.72%
- Shares outstanding 163M
- Free float 126M
Dogecoin Cash, Inc. company profile
- Company name
- Dogecoin Cash, Inc.
- Ticker
- DOGP.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Information Services
- Employees
- 4
- Fiscal year end
- December
- Address
- 355 West Mesquite Blvd, Mesquite, NV, United States, 89027
- Phone
- 702 762 3123
- Website
- dogecoincashinc.com
About Dogecoin Cash, Inc.
Dogecoin Cash, Inc., through its subsidiaries, provides online telehealth referral services through the PrestoDoctor platform in the United States. The company offers the technology platform and administrative support that facilitate telemedicine consultations between patients and licensed physicians. In addition, it maintains cannabis-related intellectual property. The company was formerly known as Cannabis Sativa, Inc. and changed its name to Dogecoin Cash, Inc. in November 2024. Dogecoin Cash, Inc. is based in Mesquite, Nevada.
Dogecoin Cash, Inc. management
3- Mr. David M. TobiasChairperson, CFO, CEO, President & Secretary · born 1951
- Ms. Catherine J. CarrollTreasurer & Director · born 1941
- Ms. Carolyn MerrillController · born 1967